Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients with Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study

Manish A. Shah, Takashi Kojima, Daniel Hochhauser, Peter Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung Bae Kim, Masahiro Tajika, Heung Tae Kim, A. Craig Lockhart, Hendrik Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Qi Liu, Jared Lunceford, S. Peter Kang, Pooja Bhagia, Ken Kato

Research output: Contribution to journalArticle

60 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients with Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences